Expansion of the Metabolomic and Cardiovascular Disease Facility at Cambridge University
Lead Research Organisation:
University of Cambridge
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Cambridge University was awarded #665K to expand the Metabolic and Cardiovascular disease facility for the development of mouse models. This will add significantly to the existing strengths at Cambridge, and directly addressed the MRC strategic priority of developing models of human disease.|Metabolic and cardiovascular diseases are major public health challenges. Additionally, therapeutic options for these disorders are very limited and thus, they represent, to industry, a considerable unmet need. Cardio-metabolic diseases are quintessentially disorders of systems, not simply cells, and studies in whole organisms are therefore essential to both the elucidation of their pathophysiology and the examination of possible novel therapies. The pharmaceutical and biotechnology industries are increasingly looking to partner with sophisticated academic laboratories to undertake sophisticated target validation and proof of concept studies in appropriately designed and refined animal models. The UK academic sector, in general, is not particularly well placed to respond to this need. However, there are key centres of excellence in specific disease areas that are uniquely placed to fulfil those needs. Cambridge University may represent such a centre in cardio-metabolic disease and the award will helps to improve the Universitys ability to carry out detailed phenotypic analysis of murine models of human metabolic and cardiovascular disease. The development and utilization of sophisticated phenotyping technologies are crucial to capitalise on the power of murine genetic manipulation and facilitate meaningful translation of basic science into the clinical arena. Cambridge aim to incorporate state of the art technologies and develop sophisticated, accurate protocols in two major phenotyping areas: 1) the characterization of central and peripheral mechanisms controlling energy balance (e.g. food intake, energy expenditure and fat deposition); and 2) the evaluation of cardiovascular complications such as hypertension, dyslipidaemia and macrovascular disease that are strongly associated with metabolic diseases such as obesity and diabetes mellitus.
Organisations
- University of Cambridge (Lead Research Organisation)
- Plasticell Ltd (Collaboration)
- EMBL European Bioinformatics Institute (EMBL - EBI) (Collaboration)
- Newcastle University (Collaboration)
- Rey Juan Carlos University Hospital (Collaboration)
- Osaka University (Collaboration)
- Nanjing University (NJU) (Collaboration)
- Chiba University (Collaboration)
- Microsoft Research (Collaboration)
- Model Animal Research Center (MARC) Nanjing (Collaboration)
- European Commission (Collaboration)
- University of Barcelona (Collaboration)
People |
ORCID iD |
Publications
Sanghez V
(2013)
Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the Metabolic Syndrome.
in Psychoneuroendocrinology
Virtue S
(2013)
Assessment of brown adipose tissue function.
in Frontiers in physiology
Clemente FJ
(2014)
A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations.
in American journal of human genetics
Yew Tan C
(2015)
Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.
in Scientific reports
Tan C
(2015)
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
in Cell Reports
Smith MA
(2015)
Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice.
in Cell reports
Patel MN
(2015)
Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.
in Proceedings of the National Academy of Sciences of the United States of America
Schreiber R
(2015)
Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.
in Proceedings of the National Academy of Sciences of the United States of America
| Title | TVPLAB twitter |
| Description | Use of Social Media TVPLAB TWITTER https://twitter.com/tvplab?lang=en-gb |
| Type Of Art | Creative Writing |
| Year Produced | 2015 |
| Impact | Creative tool to communicate our science to public |
| URL | https://twitter.com/tvplab?lang=en-gb |
| Description | ERC senior investigator |
| Amount | € 2,500,000 (EUR) |
| Funding ID | StemBAT |
| Organisation | European Research Council (ERC) |
| Sector | Public |
| Country | Belgium |
| Start | 01/2015 |
| End | 12/2023 |
| Title | 3D Culture of Stem cells |
| Description | 3D tissue culture system to study cross talk between stem cells |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2017 |
| Provided To Others? | No |
| Impact | Improvement in quality of results by better mimicking in vivo intercellular interactions. |
| Title | IT support for data storage and backup |
| Description | This enables us to have a reliable data storage system to reproduce the mass of data produced in metabolic phenotyping. Furthermore, with a goad data storage system we are able to analyze data in various ways. |
| Type Of Material | Biological samples |
| Provided To Others? | No |
| Impact | Refinement and reduction |
| Title | Mass Spectrometry to analyse lipids |
| Description | Refined technology to measure lipid composition. |
| Type Of Material | Model of mechanisms or symptoms - in vitro |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | 1. Yew Tan C, Virtue S, Murfitt S, Robert LD, Phua YH, Dale M, Griffin JL, Tinahones F, Scherer PE, Vidal-Puig A. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep. 2015 Dec 17;5:18366. doi: 10.1038/srep18366. 2. Tan CY, Virtue S, Bidault G, Dale M, Hagen R, Griffin JL, Vidal-Puig A. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6. Cell Rep. 2015 Dec 15;13(10):2039-47. doi: 10.1016/j.celrep.2015.11.004. Epub 2015 Nov 25. 3. Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601. |
| Title | Metabolic phenotyping technology |
| Description | Systems of administration of lipids in vivo as a controlled system to study lipotoxicity D20 to measure fatty acid synthesis in livers of mice. |
| Type Of Material | Model of mechanisms or symptoms - mammalian in vivo |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | Systems for controlled administration of lipids as a controlled system to study lipotoxicity D20 to measure fatty acid synthesis in livers of mice. Both approaches are very useful to investigate the effects and localisation of specific fatty acids in vivo as well as their routes of metabolisation. This allowed dynamic studies of fluxes of lipids. |
| Title | Bionash |
| Description | Data base of human liver biopsies |
| Type Of Material | Database/Collection of data |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Contribution to International consortiums such fp7 Epos and FP7 IMI LItmus |
| URL | http://www.epos-nafld.eu/ |
| Description | Chiba University |
| Organisation | Chiba University |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | Technology and animal models |
| Collaborator Contribution | Salary support for postdoctoral fellow |
| Impact | 1. Diet-Induced Obese Mice and Leptin-Deficient Lepob/ob Mice Exhibit Increased Circulating GIP Levels Produced by Different Mechanisms. Lee E, Miedzybrodzka EL, Zhang X, Hatano R, Miyamoto J, Kimura I, Fujimoto K, Uematsu S, Rodriguez-Cuenca S, Vidal-Puig A, Gribble FM, Reimann F, Miki T. Int J Mol Sci. 2019 Sep 10;20(18). pii: E4448. doi: 10.3390/ijms20184448. PMID: 31509948 Free PMC Article Similar articles Select item 26615883 2.Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565. PMID: 26615883 Free PMC Article Similar articles Select item 26584636 3.Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A, Bujo H. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951. Li J, Zhang Y, Ye Y, Li D, Liu Y, Lee E, Zhang M, Dai X, Zhang X, Wang S, Zhang J, Jia W, Zen K, Vidal-Puig A, Jiang X, Zhang CY. Pancreatic ß cells control glucose homeostasis via the secretion of exosomal miR-29 family. J Extracell Vesicles. 2021 Jan;10(3):e12055. doi: 10.1002/jev2.12055. Epub 2021 Jan 21. PMID: 33520119 An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. Lee E, Korf H, Vidal-Puig A. J Hepatol. 2023 Feb 3:S0168-8278(23)00077-6. doi: 10.1016/j.jhep.2023.01.024. Online ahead of print. PMID: 36740049 Free article. Review. |
| Start Year | 2018 |
| Description | Collaboration with University Rey Juan carlos Madrid. |
| Organisation | Rey Juan Carlos University Hospital |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Provided animal models to study Kidney lipotoxicity |
| Collaborator Contribution | Provided expertise in murine characterisation of kidney phenotypes. Provide expertise in murine metabolic phenotyping |
| Impact | 1 Obesity and pregnancy, the perfect metabolic storm. Corrales P, Vidal-Puig A, Medina-Gómez G. Eur J Clin Nutr. 2021 Dec;75(12):1723-1734. doi: 10.1038/s41430-021-00914-5. Epub 2021 Apr 28. PMID: 33911209 Review. 2. Autocrine IGF2 programmes ß-cell plasticity under conditions of increased metabolic demand. Sandovici I, Hammerle CM, Virtue S, Vivas-Garcia Y, Izquierdo-Lahuerta A, Ozanne SE, Vidal-Puig A, Medina-Gómez G, Constância M. Sci Rep. 2021 Apr 8;11(1):7717. doi: 10.1038/s41598-021-87292-x. PMID: 33833312 Free PMC article. 3. Mesenchyme-derived IGF2 is a major paracrine regulator of pancreatic growth and function. Hammerle CM, Sandovici I, Brierley GV, Smith NM, Zimmer WE, Zvetkova I, Prosser HM, Sekita Y, Lam BYH, Ma M, Cooper WN, Vidal-Puig A, Ozanne SE, Medina-Gómez G, Constância M. PLoS Genet. 2020 Oct 15;16(10):e1009069. doi: 10.1371/journal.pgen.1009069. eCollection 2020 Oct. PMID: 33057429 Transforming Growth Factor-ß3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue. Petrus P, Mejhert N, Corrales P, Lecoutre S, Li Q, Maldonado E, Kulyté A, Lopez Y, Campbell M, Acosta JR, Laurencikiene J, Douagi I, Gao H, Martínez-Álvarez C, Hedén P, Spalding KL, Vidal-Puig A, Medina-Gomez G, Arner P, Rydén M. Cell Rep. 2018 Oct 16;25(3):551-560.e5. doi: 10.1016/j.celrep.2018.09.069. PMID: 30332637 Free Article 4.PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity. Corrales P, Vidal-Puig A, Medina-Gómez G. Int J Mol Sci. 2018 Jul 21;19(7). pii: E2124. doi: 10.3390/ijms19072124. Review. PMID: 30037087 Free PMC Article 5. Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance. Martínez-Sánchez N, Seoane-Collazo P, Contreras C, Varela L, Villarroya J, Rial-Pensado E, Buqué X, Aurrekoetxea I, Delgado TC, Vázquez-Martínez R, González-García I, Roa J, Whittle AJ, Gomez-Santos B, Velagapudi V, Tung YCL, Morgan DA, Voshol PJ, Martínez de Morentin PB, López-González T, Liñares-Pose L, Gonzalez F, Chatterjee K, Sobrino T, Medina-Gómez G, Davis RJ, Casals N, Orešic M, Coll AP, Vidal-Puig A, Mittag J, Tena-Sempere M, Malagón MM, Diéguez C, Martínez-Chantar ML, Aspichueta P, Rahmouni K, Nogueiras R, Sabio G, Villarroya F, López M. Cell Metab. 2017 Jul 5;26(1):212-229.e12. doi: 10.1016/j.cmet.2017.06.014. PMID: 28683288 F |
| Start Year | 2019 |
| Description | FAtty Liver |
| Organisation | EMBL European Bioinformatics Institute (EMBL - EBI) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Murine studies to identify NASH biomarkers and molecular mechanisms of disease. Important input from the point of lipid metabolism in macrophages and signalling in Kupffer cells and stellate cells. |
| Collaborator Contribution | Newcastle: Leader 2020 Horizon Epoos and IMI Litmus. Access to human data EBI: Bioinformatic analysis - PhD Studetship |
| Impact | Funding 2020 Epoos and IMIM Litmus Santos A, Delgado TC, Marques V, Moncayo CR, Alonso C, Vidal-Puig A, Hall Z, Martínez-Chantar ML, Rodrigues CMP.Spatial metabolomics and its application in the liver. Hepatology. 2023 Feb 23. doi: 10.1097/HEP.0000000000000341. Online ahead of print. PMID: 36811413 Sen P, Govaere O, Sinioja T, McGlinchey A, Geng D, Ratziu V, Bugianesi E, Schattenberg JM, Vidal-Puig A, Allison M, Cockell S, Daly AK, Hyötyläinen T, Anstee QM, Orešic M. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience. 2022 Aug 15;25(9):104949. doi: 10.1016/j.isci.2022.104949. eCollection 2022 Sep 16. PMID: 36065182 Lee E, Korf H, Vidal-Puig A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023 Feb 3:S0168-8278(23)00077-6. doi: 10.1016/j.jhep.2023.01.024. Online ahead of print. PMID: 36740049 Free article. Review. 1. Johnson K, Leary PJ, Govaere O, Barter MJ, Charlton SH, Cockell SJ, Tiniakos D, Zatorska M, Bedossa P, Brosnan MJ, Cobbold JF, Ekstedt M, Aithal GP, Clément K, Schattenberg JM, Boursier J, Ratziu V, Bugianesi E, Anstee QM, Daly AK; LITMUS Consortium Investigators. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance. JHEP Rep. 2021 Nov 25;4(2):100409. doi: 10.1016/j.jhepr.2021.100409. PMID: 35072021 PMCID: PMC8762473 2. Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI, Mohammad T, Latham PS, Nguyen BN, Wong L, Yu H, Al-Abed Y, Mishra B, Vacca M, Guenigault G, Allison MED, Vidal-Puig A, Benhammou JN, Alvarez M, Pajukanta P, Pisegna JR, Mishra L. ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Sci Transl Med. 2021 Dec 15;13(624):eabk2267. doi:10.1126/scitranslmed.abk2267. PMID: 34910547 3. Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lup?or-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Yilmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2021 May 17:gutjnl-2021-324243. doi: 10.1136/gutjnl-2021-324243. PMID: 34001645 4. Selvaraj EA, Mózes FE, Ajmer Jayaswal AN, Zafarmand MH, Vali Y, Lee JA, Levick CK, Joseph Young LA, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021 May 12:S0168-8278(21)00309-3. doi: 10.1016/j.jhep.2021.04.044. PMID: 33991635 5. Azzu V, Vacca M, Kamzolas I, Hall Z, Leslie J, Carobbio S, Virtue S, Davies SE, Lukasik A, Dale M, Bohlooly-Y M, Acharjee A, Lindén D, Bidault G, Petsalaki E, Griffin JL, Oakley F, Allison MED, Vidal-Puig A. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. Mol Metab 1012-10. 2021. PMID:33722690 6. Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S, Boursier J, Rosso C, Johnson K, Wonders K, Day CP, Ekstedt M, Orešic M, Darlay R, Cordell HJ, Marra F, Vidal-Puig A, Bedossa P, Schattenberg JM, Clément K, Allison M, Bugianesi E, Ratziu V, Daly AK, Anstee QM. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020 Dec 2;12(572):eaba4448.doi:10.1126/scitranslmed.aba4448. PMID: 33268509 7. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Gastroenterology. 2020 Feb 12. pii: S0016-5085(20)30224-9. doi: 10.1053/j.gastro.2019.12.054. [Epub ahead of print] PMID: 32061598 Similar articles Select item 27863448 8.Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, Murray AJ, Bellafante E, Virtue S, Vidal-Puig A, Allison M, Davies SE, Koulman A, Vacca M, Griffin JL. Hepatology. 2017 Apr;65(4):1165-1180. doi: 10.1002/hep.28953. Epub 2017 Feb 6. PMID: 27863448 Free PMC Article Similar articles Select item 26378642 9.Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. Vacca M, Allison M, Griffin JL, Vidal-Puig A. Semin Liver Dis. 2015 Aug;35(3):250-61. doi: 10.1055/s-0035-1562945. Epub 2015 Sep 17. Review. PMID: 26378642 Similar articles |
| Start Year | 2016 |
| Description | FAtty Liver |
| Organisation | European Commission |
| Department | Innovative Medicines Initiative (IMI) |
| Country | Belgium |
| Sector | Public |
| PI Contribution | Murine studies to identify NASH biomarkers and molecular mechanisms of disease. Important input from the point of lipid metabolism in macrophages and signalling in Kupffer cells and stellate cells. |
| Collaborator Contribution | Newcastle: Leader 2020 Horizon Epoos and IMI Litmus. Access to human data EBI: Bioinformatic analysis - PhD Studetship |
| Impact | Funding 2020 Epoos and IMIM Litmus Santos A, Delgado TC, Marques V, Moncayo CR, Alonso C, Vidal-Puig A, Hall Z, Martínez-Chantar ML, Rodrigues CMP.Spatial metabolomics and its application in the liver. Hepatology. 2023 Feb 23. doi: 10.1097/HEP.0000000000000341. Online ahead of print. PMID: 36811413 Sen P, Govaere O, Sinioja T, McGlinchey A, Geng D, Ratziu V, Bugianesi E, Schattenberg JM, Vidal-Puig A, Allison M, Cockell S, Daly AK, Hyötyläinen T, Anstee QM, Orešic M. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience. 2022 Aug 15;25(9):104949. doi: 10.1016/j.isci.2022.104949. eCollection 2022 Sep 16. PMID: 36065182 Lee E, Korf H, Vidal-Puig A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023 Feb 3:S0168-8278(23)00077-6. doi: 10.1016/j.jhep.2023.01.024. Online ahead of print. PMID: 36740049 Free article. Review. 1. Johnson K, Leary PJ, Govaere O, Barter MJ, Charlton SH, Cockell SJ, Tiniakos D, Zatorska M, Bedossa P, Brosnan MJ, Cobbold JF, Ekstedt M, Aithal GP, Clément K, Schattenberg JM, Boursier J, Ratziu V, Bugianesi E, Anstee QM, Daly AK; LITMUS Consortium Investigators. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance. JHEP Rep. 2021 Nov 25;4(2):100409. doi: 10.1016/j.jhepr.2021.100409. PMID: 35072021 PMCID: PMC8762473 2. Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI, Mohammad T, Latham PS, Nguyen BN, Wong L, Yu H, Al-Abed Y, Mishra B, Vacca M, Guenigault G, Allison MED, Vidal-Puig A, Benhammou JN, Alvarez M, Pajukanta P, Pisegna JR, Mishra L. ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Sci Transl Med. 2021 Dec 15;13(624):eabk2267. doi:10.1126/scitranslmed.abk2267. PMID: 34910547 3. Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lup?or-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Yilmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2021 May 17:gutjnl-2021-324243. doi: 10.1136/gutjnl-2021-324243. PMID: 34001645 4. Selvaraj EA, Mózes FE, Ajmer Jayaswal AN, Zafarmand MH, Vali Y, Lee JA, Levick CK, Joseph Young LA, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021 May 12:S0168-8278(21)00309-3. doi: 10.1016/j.jhep.2021.04.044. PMID: 33991635 5. Azzu V, Vacca M, Kamzolas I, Hall Z, Leslie J, Carobbio S, Virtue S, Davies SE, Lukasik A, Dale M, Bohlooly-Y M, Acharjee A, Lindén D, Bidault G, Petsalaki E, Griffin JL, Oakley F, Allison MED, Vidal-Puig A. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. Mol Metab 1012-10. 2021. PMID:33722690 6. Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S, Boursier J, Rosso C, Johnson K, Wonders K, Day CP, Ekstedt M, Orešic M, Darlay R, Cordell HJ, Marra F, Vidal-Puig A, Bedossa P, Schattenberg JM, Clément K, Allison M, Bugianesi E, Ratziu V, Daly AK, Anstee QM. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020 Dec 2;12(572):eaba4448.doi:10.1126/scitranslmed.aba4448. PMID: 33268509 7. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Gastroenterology. 2020 Feb 12. pii: S0016-5085(20)30224-9. doi: 10.1053/j.gastro.2019.12.054. [Epub ahead of print] PMID: 32061598 Similar articles Select item 27863448 8.Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, Murray AJ, Bellafante E, Virtue S, Vidal-Puig A, Allison M, Davies SE, Koulman A, Vacca M, Griffin JL. Hepatology. 2017 Apr;65(4):1165-1180. doi: 10.1002/hep.28953. Epub 2017 Feb 6. PMID: 27863448 Free PMC Article Similar articles Select item 26378642 9.Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. Vacca M, Allison M, Griffin JL, Vidal-Puig A. Semin Liver Dis. 2015 Aug;35(3):250-61. doi: 10.1055/s-0035-1562945. Epub 2015 Sep 17. Review. PMID: 26378642 Similar articles |
| Start Year | 2016 |
| Description | FAtty Liver |
| Organisation | Newcastle University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Murine studies to identify NASH biomarkers and molecular mechanisms of disease. Important input from the point of lipid metabolism in macrophages and signalling in Kupffer cells and stellate cells. |
| Collaborator Contribution | Newcastle: Leader 2020 Horizon Epoos and IMI Litmus. Access to human data EBI: Bioinformatic analysis - PhD Studetship |
| Impact | Funding 2020 Epoos and IMIM Litmus Santos A, Delgado TC, Marques V, Moncayo CR, Alonso C, Vidal-Puig A, Hall Z, Martínez-Chantar ML, Rodrigues CMP.Spatial metabolomics and its application in the liver. Hepatology. 2023 Feb 23. doi: 10.1097/HEP.0000000000000341. Online ahead of print. PMID: 36811413 Sen P, Govaere O, Sinioja T, McGlinchey A, Geng D, Ratziu V, Bugianesi E, Schattenberg JM, Vidal-Puig A, Allison M, Cockell S, Daly AK, Hyötyläinen T, Anstee QM, Orešic M. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience. 2022 Aug 15;25(9):104949. doi: 10.1016/j.isci.2022.104949. eCollection 2022 Sep 16. PMID: 36065182 Lee E, Korf H, Vidal-Puig A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023 Feb 3:S0168-8278(23)00077-6. doi: 10.1016/j.jhep.2023.01.024. Online ahead of print. PMID: 36740049 Free article. Review. 1. Johnson K, Leary PJ, Govaere O, Barter MJ, Charlton SH, Cockell SJ, Tiniakos D, Zatorska M, Bedossa P, Brosnan MJ, Cobbold JF, Ekstedt M, Aithal GP, Clément K, Schattenberg JM, Boursier J, Ratziu V, Bugianesi E, Anstee QM, Daly AK; LITMUS Consortium Investigators. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance. JHEP Rep. 2021 Nov 25;4(2):100409. doi: 10.1016/j.jhepr.2021.100409. PMID: 35072021 PMCID: PMC8762473 2. Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI, Mohammad T, Latham PS, Nguyen BN, Wong L, Yu H, Al-Abed Y, Mishra B, Vacca M, Guenigault G, Allison MED, Vidal-Puig A, Benhammou JN, Alvarez M, Pajukanta P, Pisegna JR, Mishra L. ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Sci Transl Med. 2021 Dec 15;13(624):eabk2267. doi:10.1126/scitranslmed.abk2267. PMID: 34910547 3. Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lup?or-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Yilmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2021 May 17:gutjnl-2021-324243. doi: 10.1136/gutjnl-2021-324243. PMID: 34001645 4. Selvaraj EA, Mózes FE, Ajmer Jayaswal AN, Zafarmand MH, Vali Y, Lee JA, Levick CK, Joseph Young LA, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021 May 12:S0168-8278(21)00309-3. doi: 10.1016/j.jhep.2021.04.044. PMID: 33991635 5. Azzu V, Vacca M, Kamzolas I, Hall Z, Leslie J, Carobbio S, Virtue S, Davies SE, Lukasik A, Dale M, Bohlooly-Y M, Acharjee A, Lindén D, Bidault G, Petsalaki E, Griffin JL, Oakley F, Allison MED, Vidal-Puig A. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. Mol Metab 1012-10. 2021. PMID:33722690 6. Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S, Boursier J, Rosso C, Johnson K, Wonders K, Day CP, Ekstedt M, Orešic M, Darlay R, Cordell HJ, Marra F, Vidal-Puig A, Bedossa P, Schattenberg JM, Clément K, Allison M, Bugianesi E, Ratziu V, Daly AK, Anstee QM. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020 Dec 2;12(572):eaba4448.doi:10.1126/scitranslmed.aba4448. PMID: 33268509 7. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Gastroenterology. 2020 Feb 12. pii: S0016-5085(20)30224-9. doi: 10.1053/j.gastro.2019.12.054. [Epub ahead of print] PMID: 32061598 Similar articles Select item 27863448 8.Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, Murray AJ, Bellafante E, Virtue S, Vidal-Puig A, Allison M, Davies SE, Koulman A, Vacca M, Griffin JL. Hepatology. 2017 Apr;65(4):1165-1180. doi: 10.1002/hep.28953. Epub 2017 Feb 6. PMID: 27863448 Free PMC Article Similar articles Select item 26378642 9.Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. Vacca M, Allison M, Griffin JL, Vidal-Puig A. Semin Liver Dis. 2015 Aug;35(3):250-61. doi: 10.1055/s-0035-1562945. Epub 2015 Sep 17. Review. PMID: 26378642 Similar articles |
| Start Year | 2016 |
| Description | Joint Unit CIPF-CAMBRIDGE Obesity and Metabolic Regulation |
| Organisation | Microsoft Research |
| Department | Microsoft Research Cambridge |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Genetic engineering of human pluripotent stem cells |
| Collaborator Contribution | Validation of Phenotyping of cells (CIPF). KAUST (AI Application to identify reposition of compounds) Microsoft Cambridge (Bioinformatic Analysis) Cite s |
| Impact | Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK. Artero Castro A, Long K, Bassett A, Machuca C, León M, Ávila-Fernandez A, Cortón M, Vidal-Puig T, Ayuso C, Lukovic D, Erceg S. Stem Cell Res. 2019 Jan;34:101341. doi: 10.1016/j.scr.2018.11.003. Epub 2018 Nov 16. PMID: 30612079 Free Article Artero Castro A, Long K, Bassett A, Machuca C, León M, Ávila-Fernandez A, Cortón M, Vidal-Puig T, Ayuso C, Lukovic D, Erceg S.Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK Stem Cell Res. 2019 Jan;34:101341. doi: 10.1016/j.scr.2018.11.003. Epub 2018 Nov 16. PMID: 30612079 Free article. 2 Carobbio S, Guenantin AC, Bahri M, Rodriguez-Fdez S, Honig F, Kamzolas I, Samuelson I, Long K, Awad S, Lukovic D, Erceg S, Bassett A, Mendjan S, Vallier L, Rosen BS, Chiarugi D, Vidal-Puig A.Unraveling the developmental roadmap toward human brown adipose tissue. Stem Cell Reports. 2021 Feb 6:S2213-6711(21)00043-6. doi: 10.1016/j.stemcr.2021.01.013. Online ahead of print. PMID: 33606988 Free article.enetic engineering of Cell |
| Start Year | 2017 |
| Description | LPGD2S KO MOUSe |
| Organisation | Osaka University |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | Phenotyping of mouse models |
| Collaborator Contribution | provided animal models for MRC funded project. |
| Impact | Papers still under submission expected to be published during 2010 |
| Start Year | 2007 |
| Description | NANJING/SUZHOU |
| Organisation | Model Animal Research Center (MARC) Nanjing |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Provide expertise in murine metabolic phenotyping |
| Collaborator Contribution | Phenotyping of mice and PhD studentship |
| Impact | N/A • Prof. Antonio Vidal-Puig is a concurrent professor at Nanjing University appointed in September of 2017. • A joint lab focusing on non-alcoholic fatty liver disease has been established at MARC in 2017, co-headed by Profs. Antonio Vidal-Puig and Shuai Chen. • Strong collaborative links with professor Chen Yu Zhang at the Institute of Life Sciences of the University of Nanjing to identify mechanism of disease in metabolic disorders. CYZ is one of the leaders in the development of Biology AI 3.0 in Nanjing • Prof. Antonio Vidal-Puig visits Nanjing University at least twice a year and gives lectures. • A joint workshop on metabolic diseases is to be held in May of 2019 in Nanjing. Six scientists including Prof. Antonio Vidal-Puig from Cambridge and 15 scientists from Nanjing University will attend this workshop.Nanjing, China. 19th-25th May 2019. The Sino-UK Cardiovascular disease symposium. Cambridge, United Kingdom. 5th July 2019 Joint work shop by Cambridge University Nanjing Centre of Technology and Innovation, Institute Metabolic Science, University of Cambridge, Model Animals Research Centre (MARC), University of Nanjing. Huang-Doran I, Zhang CY, Vidal-Puig A. Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease. Trends Endocrinol Metab. 2017 Jan;28(1):3-18. doi: 10.1016/j.tem.2016.10.003. Epub 2016 Oct 31. PMID: 27810172 Review. 2 Cite Share Li J, Zhang Y, Ye Y, Li D, Liu Y, Lee E, Zhang M, Dai X, Zhang X, Wang S, Zhang J, Jia W, Zen K, Vidal-Puig A, Jiang X, Zhang CY. Pancreatic ß cells control glucose homeostasis via the secretion of exosomal miR-29 family.J Extracell Vesicles. 2021 Jan;10(3):e12055. doi: 10.1002/jev2.12055. Epub 2021 Jan 21. PMID: 33520119 Free PMC article. |
| Start Year | 2018 |
| Description | NANJING/SUZHOU |
| Organisation | Nanjing University (NJU) |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Provide expertise in murine metabolic phenotyping |
| Collaborator Contribution | Phenotyping of mice and PhD studentship |
| Impact | N/A • Prof. Antonio Vidal-Puig is a concurrent professor at Nanjing University appointed in September of 2017. • A joint lab focusing on non-alcoholic fatty liver disease has been established at MARC in 2017, co-headed by Profs. Antonio Vidal-Puig and Shuai Chen. • Strong collaborative links with professor Chen Yu Zhang at the Institute of Life Sciences of the University of Nanjing to identify mechanism of disease in metabolic disorders. CYZ is one of the leaders in the development of Biology AI 3.0 in Nanjing • Prof. Antonio Vidal-Puig visits Nanjing University at least twice a year and gives lectures. • A joint workshop on metabolic diseases is to be held in May of 2019 in Nanjing. Six scientists including Prof. Antonio Vidal-Puig from Cambridge and 15 scientists from Nanjing University will attend this workshop.Nanjing, China. 19th-25th May 2019. The Sino-UK Cardiovascular disease symposium. Cambridge, United Kingdom. 5th July 2019 Joint work shop by Cambridge University Nanjing Centre of Technology and Innovation, Institute Metabolic Science, University of Cambridge, Model Animals Research Centre (MARC), University of Nanjing. Huang-Doran I, Zhang CY, Vidal-Puig A. Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease. Trends Endocrinol Metab. 2017 Jan;28(1):3-18. doi: 10.1016/j.tem.2016.10.003. Epub 2016 Oct 31. PMID: 27810172 Review. 2 Cite Share Li J, Zhang Y, Ye Y, Li D, Liu Y, Lee E, Zhang M, Dai X, Zhang X, Wang S, Zhang J, Jia W, Zen K, Vidal-Puig A, Jiang X, Zhang CY. Pancreatic ß cells control glucose homeostasis via the secretion of exosomal miR-29 family.J Extracell Vesicles. 2021 Jan;10(3):e12055. doi: 10.1002/jev2.12055. Epub 2021 Jan 21. PMID: 33520119 Free PMC article. |
| Start Year | 2018 |
| Description | Plasticell: "In vivo activation of brown adipose tissue by plant-derived natural extracts", Innovation |
| Organisation | Plasticell Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Knowledge on mouse murine phenotyping |
| Collaborator Contribution | Technology in conbinatorial optimisation of Stem cell differentiation. |
| Impact | Multidisciplinary combining our unique expertise |
| Start Year | 2017 |
| Description | Univerisdad de Barcelona- |
| Organisation | University of Barcelona |
| Country | Spain |
| Sector | Academic/University |
| PI Contribution | Provide genetically modified murine models and technological support for phenotyping |
| Collaborator Contribution | Specific knowledge in the analysis of CPT1 mutants. This is a very specific type of specialised knowledge that provides us with competitive advantage |
| Impact | 1. Allostatic hypermetabolic response in PGC1a/ß heterozygote mouse despite mitochondrial defects. Rodriguez-Cuenca S, Lelliot CJ, Campbell M, Peddinti G, Martinez-Uña M, Ingvorsen C, Dias AR, Relat J, Mora S, Hyötyläinen T, Zorzano A, Orešic M, Bjursell M, Bohlooly-Y M, Lindén D, Vidal-Puig A. FASEB J. 2021 Sep;35(9):e21752. doi: 10.1096/fj.202100262RR. PMID: 34369602 2. P465L-PPAR? mutation confers partial resistance to the hypolipidaemic action of fibrates. Rodriguez-Cuenca S, Carobbio S, Barceló-Coblijn G, Prieur X, Relat J, Amat R, Campbell M, Dias AR, Bahri M, Gray SL, Vidal-Puig A. Diabetes Obes Metab. 2018 Oct;20(10):2339-2350. doi: 10.1111/dom.13370. Epub 2018 Jun 27. PMID: 29790245 Free PMC Article Similar articles Select item 26584636 Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A, Bujo H. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951. PMID: 26584636 Free PMC Article Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function. Barbarroja N, Rodriguez-Cuenca S, Nygren H, Camargo A, Pirraco A, Relat J, Cuadrado I, Pellegrinelli V, Medina-Gomez G, Lopez-Pedrera C, Tinahones FJ, Symons JD, Summers SA, Oresic M, Vidal-Puig A. Diabetes. 2015 Apr;64(4):1180-92. doi: 10.2337/db14-0359. Epub 2014 Oct 28. PMID: 25352638 Free Article Trends Pharmacol Sci. 2013 Jun;34(6):347-55. doi: 10.1016/j.tips.2013.04.004. Epub 2013 May 3. Pharmacological strategies for targeting BAT thermogenesis. Whittle A1, Relat-Pardo J, Vidal-Puig A. |
| Start Year | 2018 |
| Description | 2019: An interview with PhD student Jennie Leggat on CBBC - |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | 2019: An interview with PhD student Jennie Leggat on CBBC - https://www.bbc.co.uk/iplayer/episode/m000cgln/operation-ouch-series-8-15-food-poo-and-you |
| Year(s) Of Engagement Activity | 2019 |
| Description | 1. London, UK. 10th -11th February 2020. 3rd Global nonalcoholic steatohepatitis (NASH) Congress and co-located 1st Metabolic Syndrome, Diabetes and nonalcoholic fatty liver disease (NAFLD) Congress London. |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | 1. London, UK. 10th -11th February 2020. 3rd Global nonalcoholic steatohepatitis (NASH) Congress and co-located 1st Metabolic Syndrome, Diabetes and nonalcoholic fatty liver disease (NAFLD) Congress London. Key meeting to engage with industry. |
| Year(s) Of Engagement Activity | 2020 |
| URL | http://www.global-engage.com/event/nash/ |
| Description | 2019: An educational video on diabetes from Senior Research Associate Sam Virtue |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | 2 019: An educational video on diabetes from Senior Research Associate Sam Virtue https://www.youtube.com/watch?v=YmgYhDHl55c&t=2s. https://www.youtube.com/watch?v=bYSXqTAJBOo&t=8s |
| Year(s) Of Engagement Activity | 2019 |
| Description | 36 Congreso Sociedad Española de Farmacología. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | http://congresosef2015.com/programa-cientifico/esquema-del-programa/ 12:30 - 13:30 Sesión Plenaria. Moderadora: Dra. Mª Jesús Sanz Ferrando Universitat de València. Adipose tissue expandability, lipotoxicity and the metabolic syndrome. Prof. Antonio Vidal Puig University of Cambridge. Reino Unido. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://congresosef2015.com/programa-cientifico/esquema-del-programa/ |
| Description | 4. Bradford, UK. 1st December 2018. SRUK Seminar (Society of Spanish Researchers in the UK). |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | 4. Bradford, UK. 1st December 2018. SRUK Seminar (Society of Spanish Researchers in the UK). |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.eventbrite.co.uk/e/v-christmas-seminar-science-of-healthy-diet-sports-wellbeing-tickets-... |
| Description | 5. London, UK. 30th October 2018. California Walnut Commission Scientific & Health Research Meeting. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | 5. London, UK. 30th October 2018. California Walnut Commission Scientific & Health Research Meeting. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.bighospitality.co.uk/News/Promotional-Features/California-Walnut-Culinary-Institute-of-A... |
| Description | 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Lecture American Diabetes Association Conference 2015 |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://professional2.diabetes.org/Presentations_Details.aspx?typ=10&sr=adv&cgr=238&congress=238 |
| Description | Barcelona, Spain. 24th-27th May 2017. EMBO workshop meeting on BAT. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Barcelona, Spain. 24th-27th May 2017. EMBO workshop meeting on BAT. Conference lecturer |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://meetings.embo.org/event/17-brown-fat |
| Description | Bilbao, Spain. 8th June 2018. Seminar at Biogune. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | 7. Bilbao, Spain. 8th June 2018. Seminar at Biogune. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://twitter.com/CICbioGUNE |
| Description | Cambridge Metabolic Network/Danish Diabetes Association Course for PhD Students. |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Undergraduate students |
| Results and Impact | Course sponsored by NOVO foundation from Denmark, 35 PhD students from Cambridge and Denmark. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.danishdiabetesacademy.dk/events/lipid-metabolism-new-methods-and-translational-aspects |
| Description | Cambridge Science Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Cambridge Science Festival - covering all aspects of the world-leading research happening at Cambridge |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.tvplab-cambridge.com/post/diana-cambridge_festival-2021 |
| Description | Cambridge, United Kingdom. 2nd -4th July 2019 EAS Advanced Course in Cardiometabolic Phenotyping |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Cambridge, United Kingdom. 2nd -4th July 2019 EAS Advanced Course in Cardiometabolic Phenotyping Training hands on to develop expertise in cardiometabolic phenotyping |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.eas-society.org/events/EventDetails.aspx?id=1211946 |
| Description | Centre on AI technology for Humankind NUS Business school |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | The development of Artificial Intelligence (AI) promises amazing opportunities for transforming our lives and the way we work. It will help elevate our human potential in ways we cannot yet see or even imagine. But what are the challenges that lie ahead? Amid the hype and excitement, there is a risk that allowing technology alone to dictate the course of development may bring with it as yet unknown threats to our human condition. At AiTH, we believe that the development of AI technologies must be understood and examined in the context of collaboration and co-creation with humans. Our aim is to study, explore and develop deep insights into how AI technologies should be advanced with human-centred choices, promoting creativity and happiness whilst serving and enhancing human identity. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://bschool.nus.edu.sg/aith/people/international-research-affiliate/ |
| Description | China Medical University Conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | China Medical University Conference - "The First International Conference on the Comprehensive Life Course Prevention and Treatment of Obesity and Related Chronic Diseases" |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://en.chinacdc.cn/news/latest/202201/t20220105_255718.html |
| Description | Dusseldorf, Germany. 10th October 2017. Universitäts Klinikum Lecture Series - CRC1116 "master switches after myocardial infarction" |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Dusseldorf, Germany. 10th October 2017. Universitäts Klinikum Lecture Series - CRC1116 "master switches after myocardial infarction" |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.irtg1902.hhu.de/schedule/schedule-single-view.html?tx_cal_controller%5Bgetdate%5D=2017101... |
| Description | EAS Advanced Course in Cardiometabolic Phenotyping in Rodents. |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | EAS Advanced in Cardiometabolic Phenotyping in Rodents, Cambridge, UK Scientists from the University of Cambridge Biomedical Campus recently hosted the 2nd EAS Advanced Course in Cardiometabolic Phenotyping in Rodents. This 3-day course combines the state of the art facilities and expertise within the Disease Model Core at the WellcomeTrust-MRC Institute of Metabolic Science and the BHF Cardiovascular Centre. By integrating the expertise of these two specialized phenotyping centres, it provides a unique opportunity to learn about many of the skills required for in depth cardiometabolic phenotyping in small animals. The 32 participants, selected from centres across Europe, were treated to a programme of lectures, phenotyping demonstrations and data analysis sessions. A further 1-day workshop at the Sanger/EBI focused on mouse genetics, genetic engineering and informatics resources, highlighting the great opportunities provided by recent advances in genetic engineering purpose-made mouse models. Participants particularly appreciated the mixture of hands-on experience, combined with opportunities to ask detailed questions on how the techniques demonstrated should be used to suit their own research priorities. The course was sponsored by the European Atherosclerosis Society, British Heart Foundation and TSE systems, with organisation led by Prof Toni Vidal-Puig, Director of the MRC Metabolic Diseases Unit Disease Model Core. |
| Year(s) Of Engagement Activity | 2015 |
| URL | http://tvp.mrl.ims.cam.ac.uk/events/ |
| Description | EASD virtual meeting. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This was a meeting at the EASD Virtual Symposium, 29th September 2021. "What's the matter with adipose tissue and insulin resistance?" |
| Year(s) Of Engagement Activity | 2016,2021 |
| URL | https://www.easd.org/virtualmeeting/home.html%20#!resources/adipose-tissue-as-a-major-determinant-of... |
| Description | Form the future Careers Carousel at Sawston Village College |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Form the future Careers Carousel at Sawston Village College |
| Year(s) Of Engagement Activity | 2017 |
| Description | I'm a Scientist - Get Me Out of Here! |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Schools |
| Results and Impact | I'm a Scientist - Get Me Out of Here! During the lockdown, two members of the TVP Lab - Sonia & Jennie - took part in the MRC initiative 'I'm a Scientist - Stay at Home!'. This programme was established to allow school children to talk to real scientists during their virtual science lessons in the summer term, to find out more about the subjects they were interested in! Sonia was in the 'Disease Detectives Zone', while Jennie was in the 'Medical Research Zone'. They both had a lot of fun, and were amazed by how insightful the questions they received were! |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://imascientist.org.uk/ |
| Description | Keystone Symposia on Diabetes/Obesity and Adipose Tissue Biology. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Keystone Conference Lecture. Colorado, USA. 22nd - 27th January 2017. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://healthdocbox.com/amp/69735120-Diabetes/Diabetes-january-22-26-2017-keystone-conference-center... |
| Description | LASA (Laboratory Animal Science Association) IAT (Institute of Animal Technology) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | More than 100 LASA members attended and the content was specifically related to either maintenance of specific animal models, thermoregulation (technical challenges in achieving correct housing temperatures) as well as a in house design for small animal metabolic phenotyping. We have been approached by other academic institutions and companies to provide advice on metabolic phenotyping and to request technical support to develop their own programmes. Also we are increaisngly receiving request to review grants based on technology for murine phenotyping. |
| Year(s) Of Engagement Activity | 2009,2010 |
| Description | Lab Leadership in a Crisis |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Lab Leadership in a Crisis The Covid-19 pandemic has resulted in more people working from home, fewer people working in the laboratory, changes in the pattern of scientific interactions, physical barriers to direct communication, all in a context of anxiety and uncertainty about the present and the future. These difficulties are causing mental health problems, frustration, anger, and disengagement. However, this turbulent time has also enabled new, unexpected leaders to emerge, performing more autonomously and making insightful decisions. This period has provided them with opportunities to show their character, determination and resilience when confronted with challenges. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://alumni.bhf.org.uk/news/390927 |
| Description | Linkedin Social media |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | https://www.linkedin.com/in/toni-vidal-puig-md-phd-frcp-fmedsci-emba-43804113/detail/recent-activity/shares/ This is my most powerful social media communication channel with 5300 selected followers coming from science, business, academia. Communications include science-related communication and management of research-intensive institutions |
| Year(s) Of Engagement Activity | 2016,2017,2018,2019,2020,2021,2022 |
| URL | https://www.linkedin.com/in/toni-vidal-puig-md-phd-frcp-fmedsci-emba-43804113/detail/recent-activity... |
| Description | Lisbon, Portugal. 11th-15th September 2017. 53rd EASD Annual Meeting. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Lisbon, Portugal. 11th-15th September 2017. 53rd EASD Annual Meeting. >150 attendants to symposium on Obesity associated metabolic complications. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://d-net.idf.org/en/events/369-53rd-easd-annual-meeting-in-lisbon-portugal.html |
| Description | MIddle EaSt obesity |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Professors Toni Vidal-Puig MD PhD FRCP FMedSci EMBA and Meis Moukayed have honoured us by writing the fascinating article, People with obesity: Their heroic battle to defeat their genes in a hostile hypercaloric sedentary environment. The professors explain why more than 50 human genes, the environment and lifestyle culture all contribute to why it is not so easy as the doctor telling the patient to lose weight. In addition to looking at the 'why' of obesity, |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.middleeastmedicalportal.com/product/november-december-2018/ |
| Description | Majorca, Spain. 16th October 2017. Seminar at Illes Balears Institute for Health Research. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Majorca, Spain. 16th October 2017. Seminar at Illes Balears Institute for Health Research. Research seminar. >80 attendees. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.arabalears.cat/balears/Antonio-Vidal-Puig-nostres-estalviadors-lluitar_0_1892210855.html |
| Description | Malaga, Spain. 20th-23rd March 2017. Danish Diabetes Academy Postdoc Winter School |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Undergraduate students |
| Results and Impact | On March 19-24, 2017, a total of 99 Post Doc fellows, third-year PhD students and prominent national and international speakers attended Danish Diabetes Academy's 3rd Winter School in Malaga with focus on different aspects of prevention and treatment of diabetes as well as career development. Malaga, Spain. 20th-23rd March 2017. Danish Diabetes Academy Postdoc Winter School. . |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.danishdiabetesacademy.dk/node/1087 |
| Description | Naked scientist podcad |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Undergraduate students |
| Results and Impact | Senior Research Associate of pour laboratory Sam Virtue on the Naked Scientist podcast - https://www.thenakedscientists.com/podcasts/naked-scientists-podcast/qa-soy-slingshots-and-cyanide & https://www.thenakedscientists.com/podcasts/naked-scientists-podcast/qa-atoms-avalanches-armpits |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.thenakedscientists.com/podcasts/naked-scientists-podcast/qa-soy-slingshots-and-cyanide. |
| Description | Naples, Italy. 28th May 2018. Seminar at The Institute of Genetics and Biophysics "Adriano Buzzati-Traverso" of the National Research Council (CNR). |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Naples, Italy. 28th May 2018. Seminar at The Institute of Genetics and Biophysics "Adriano Buzzati-Traverso" of the National Research Council (CNR). Lecture on the Adipose tissue expandability, lipotoxicity and metabolic syndrome. |
| Year(s) Of Engagement Activity | 2018 |
| Description | Paris, France. 11th-15th April 2018. EASL International Liver Congress. |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation at the Paris, France. 11th-15th April 2018. EASL International Liver Congress focused on the pathogenesis of fatty liver and the effect of Lipotoxicty |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://easl.eu/discover/events/detail/2018/the-international-liver-congress-2018 |
| Description | Presentation at AALAS (American Association of Laboratory Animal Science |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Health professionals |
| Results and Impact | Attending more than 150 membersof AALAS, we presented our expertise in mouse husbandry and metabolic phenotyping technology development. Increased demand for technical advice related to murine husbandry and technological developments for murine phenotyping. |
| Year(s) Of Engagement Activity | 2009,2010 |
| Description | Presentation at the Institute of Safety in Technology and Research |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Participants in your research and patient groups |
| Results and Impact | Presentations have been given regarding Health and Safety issues at ISTR (Institute of Safety in Technology and Research) on safe transport of biological materials. Increased awareness on issues related to safe transport are expected to improve safety. |
| Year(s) Of Engagement Activity | 2009,2010 |
| Description | Public engagement at the Suffolk Science Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | On Monday February 17th 2020, a team of PhD students from the Institute of Metabolic Science went to the Suffolk Science Festival in Bury St. Edmunds to teach local children about neurons, the anatomy of the gastrointestinal system and the importance of insulin sensitivity. Among the team was TVP lab PhD student Jennie Leggat. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.tvplab-cambridge.com/post/public-engagement-at-the-suffolk-science-festival |
| Description | Royal Swedish Academy of Sciences, Journal of Internal Medicine - Key Symposium "Metabolic complications of obesity" |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Organisation of symposia with 150 attendants, 28 speakers from EU, USA, JAPAN, CHINA. Top symposium supported by the Swedish Academy of Sciences and the Journal of Internal Medicine. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.mrl.ims.cam.ac.uk/event/metabolic-complications-obesity/ |
| Description | Seminar at The Diabetes Research Center, University of Iowa |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Iowa, USA (virtual). 4th October 2021. Seminar at The Diabetes Research Center, University of Iowa |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://medicine.uiowa.edu/diabetes/event/76651 |
| Description | Seminar at the Center for Diabetes and Metabolic Diseases, Medical Faculty, Indiana University. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | 2. Indiana, USA (virtual). 13th December 2021. Seminar at the Center for Diabetes and Metabolic Diseases, Medical Faculty, Indiana University. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://medicine.iu.edu/research-centers/diabetes/enrichment/seminar-series |
| Description | Toulouse, France. 28th April 2017. Seminar at INSERM. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Toulouse, France. 28th April 2017. Seminar at INSERM. Dissemination of research outcomes to research commnity |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.stromalab.fr/actualites/pr-toni-vidal-puig-university-of-cambridge-uk/ |